Why Novo Nordisk Stock Sank on Tuesday

Why Novo Nordisk Stock Sank on Tuesday

Source: 
Motley Fool
snippet: 
  • A media report detailed the lack of staying power of weight loss drugs.
  • Novo Nordisk has gained fame and popularity as the developer of one of those, Wegovy.